Flexion Therapeutics Overview

Flexion Therapeutics Gross Profit

Gross Profit analysis for FLXN.

Quarterly Gross Profit

$17.60M

↓ 5.04% YoY

As of Sep 30, 2021

Annual Gross Profit (TTM)

$79.25M

↑ 19.92% YoY

Trailing 12 months ending Sep 30, 2021

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin